Suppr超能文献

肝移植受者中 CD86、CD95 和 CD95L 分子可溶性形式的演变。

Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.

机构信息

Immunology Service, University Hospital Virgen de la Arrixaca, Murcia, Spain.

出版信息

Transpl Immunol. 2012 Mar;26(2-3):94-100. doi: 10.1016/j.trim.2011.12.001. Epub 2011 Dec 13.

Abstract

Co-stimulatory factors such as CD86 and apoptotic molecules such as CD95 and CD95L required to start and to turn off the allogenic immune response may also be present as soluble proteins. To determine the role of the soluble forms of CD86 (sCD86), CD95 (sCD95) and CD95L (sCD95L) in the outcome of liver transplants, we analyzed the circulating levels of these molecules in patients subjected to liver transplantation in the pre-operative period and during the first month post-transplantation. Serum samples were obtained from sixty-nine first orthotopic liver transplants (OLT). The patients were classified into acute rejection (AR=24) and not acute rejection (NAR=45), or considering the presence of chronic active hepatitis B or C (VP=30) or other primary liver diseases (VN=39). The levels of sCD86, sCD95 and sCD95L were analyzed by solid phase sandwich enzyme-linked immunoabsorbent assays. Our results first showed that the pre-transplantation serum levels of sCD86 in the AR group were significantly higher than in the NAR group (1007±82U/mL vs. 739±46U/mL, p=0.006), and in the post-transplantation period these levels decreased sharply. Second, the levels of sCD95L and sCD95 in the pre-transplantation period did not point to statistically significant differences between the AR and NAR groups. Considering primary liver disease, the pre-transplantation levels of sCD86 and sCD95L in the VP group were significantly higher than those of the VN group (VP, 977±69U/mL vs. VN, 722±51U/mL, p<0.002, and VP, 482±78pg/mL vs. VN, 221±31pg/mL, p=0.002, respectively). Multivariate analysis revealed that only the pre-transplantation levels of sCD86 were independently associated with the development of episodes of acute rejection (p=0.005, OR=2.1, IC 95%=1.27-3.47). In conclusion, the present work shows that primary liver disease could influence the pre-transplantation levels of sCD86 and sCD95L. High pre-transplantation serum levels of sCD86 could favor the development of episodes of acute rejection.

摘要

共刺激因子如 CD86 和凋亡分子如 CD95 和 CD95L,这些都是启动和关闭同种异体免疫反应所必需的,也可能以可溶性蛋白的形式存在。为了确定可溶性 CD86(sCD86)、CD95(sCD95)和 CD95L(sCD95L)在肝移植结果中的作用,我们分析了术前和移植后第一个月接受肝移植的患者循环中这些分子的水平。从 69 例原位肝移植(OLT)患者中获得血清样本。患者分为急性排斥反应(AR=24)和非急性排斥反应(NAR=45),或考虑慢性乙型或丙型活动性肝炎(VP=30)或其他原发性肝脏疾病(VN=39)。通过固相夹心酶联免疫吸附试验分析 sCD86、sCD95 和 sCD95L 的水平。我们的研究结果首先表明,AR 组移植前血清 sCD86 水平明显高于 NAR 组(1007±82U/mL 比 739±46U/mL,p=0.006),且在移植后这些水平急剧下降。其次,在移植前,AR 组和 NAR 组之间 sCD95L 和 sCD95 的水平没有统计学意义。考虑到原发性肝脏疾病,VP 组移植前 sCD86 和 sCD95L 的水平明显高于 VN 组(VP,977±69U/mL 比 VN,722±51U/mL,p<0.002,和 VP,482±78pg/mL 比 VN,221±31pg/mL,p=0.002)。多变量分析显示,只有移植前 sCD86 水平与急性排斥反应的发生独立相关(p=0.005,OR=2.1,95%CI=1.27-3.47)。总之,本研究表明,原发性肝脏疾病可能影响移植前 sCD86 和 sCD95L 的水平。高移植前 sCD86 血清水平可能有利于急性排斥反应的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验